{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:41:43Z","timestamp":1793374903011,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>China has the largest number of patients on maintenance hemodialysis (MHD) worldwide. Despite continuous improvements in hemodialysis techniques, patients on MHD have a higher mortality rate than the general population. Understanding the characteristics of death in this population can better promote clinical practice, thereby improving patients\u2019 survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We collected demographic and clinical data for patients on MHD registered in the Beijing Blood Purification Quality Control and Improvement Center database from 2014 to 2020. The annual mortality rate was calculatedand the primary cause of end-stage renal disease (ESRD), dialysis vintage, and cause of death among deceased patients were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>(1) 24,363 patients on MHD were included, of which 6,065 patients died from 2014 to 2020. The annual mortality rate fluctuated between 7.4% and 8.0%. The median age of death was 70.0 (60.8\u201379.0) years and the male to female ratio was 1.27:1 (2). The top three primary causes of ESRD in deceased patients were chronic glomerulonephritis (CGN), diabetic nephropathy (DN), and hypertensive nephropathy (HN). Comparison of the annual mortality rate showed DN\u2009&gt;\u2009HN\u2009&gt;\u2009CGN (3). The median dialysis vintage of deceased patients was 3.7 (1.8\u20136.9) years, which slowly increased annually. Patients with diabetes had a shorter dialysis vintage than patients without diabetes (3.4 vs. 4.1 years, Z\u2009=\u20098.3, P\u2009&lt;\u20090.001) (4). The major causes of death were cardiovascular disease (20.2%), sudden death (18.1%), infection (17.9%), and cerebrovascular disease (12.6%). Proportions of death from cardiovascular disease, infection, and sudden death were higher in patients with diabetes (22.2%, 20.2%, and 20.0%) than patients without diabetes (18.4%, 15.8%, and 16.3%). Sudden death was the leading cause of death in young (18\u201344 years; 27.0%) and middle aged (45\u201364 years; 20.8%) patients, whereas infection was the leading cause of death in patients aged\u2009\u2265\u200975 years (24.5%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The annual mortality rate of patients on MHD in Beijing was relatively stable from 2014 to 2020. Sudden death was more likely to occur in young and middle-aged patients, and more patients aged\u2009\u2265\u200975 years died from infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-023-03271-6","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T01:01:41Z","timestamp":1692061301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Epidemiological analysis of death among patients on maintenance hemodialysis: results from the beijing blood purification quality Control and Improvement Center"],"prefix":"10.1186","volume":"24","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongli","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongdong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"issue":"05","key":"3271_CR1","first-page":"19","volume":"36","author":"Xiangmei Chen","year":"2021","unstructured":"Xiangmei Chen. Current status and future of the development of nephrology in China. China Med News. 2021;36(05):19\u20139.","journal-title":"China Med News"},{"issue":"2","key":"3271_CR2","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1016\/j.kisu.2020.09.001","volume":"10","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhao MH, Zuo L, Wang Y, Yu F, Zhang H, et al. China kidney Disease Network (CK-NET) 2016 Annual Data Report. Kidney Int Suppl (2011). 2020;10(2):e97\u20137185.","journal-title":"Kidney Int Suppl (2011)"},{"issue":"1","key":"3271_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/ckj\/sfaa271","volume":"14","author":"A Kramer","year":"2021","unstructured":"Kramer A, Boenink R, Stel VS, Santiuste de Pablos C, Tomovi\u0107 F, Golan E, et al. The ERA-EDTA Registry Annual Report 2018: a summary. Clin Kidney J. 2021;14(1):107\u201323.","journal-title":"Clin Kidney J"},{"issue":"3","key":"3271_CR4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/ndt\/gfs326","volume":"28","author":"X Cheng","year":"2013","unstructured":"Cheng X, Nayyar S, Wang M, Li X, Sun Y, Huang W, et al. Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. Nephrol Dial Transplant. 2013;28(3):724\u201332.","journal-title":"Nephrol Dial Transplant"},{"issue":"08","key":"3271_CR5","first-page":"562","volume":"19","author":"S Yonglong Min","year":"2020","unstructured":"Yonglong Min S, Fei D, He, et al. Epidemiological analysis of patients who died of hemodialysis in Wuhan. Chin J Blood Purif. 2020;19(08):562\u201365.","journal-title":"Chin J Blood Purif"},{"issue":"05","key":"3271_CR6","first-page":"233","volume":"11","author":"W Zhang","year":"2012","unstructured":"Zhang W, Qian J. Current status of dialysis therapy in Shanghai (results from Shanghai Renal Registry, 2011). Chin J Blood Purif. 2012;11(05):233\u201336.","journal-title":"Chin J Blood Purif"},{"key":"3271_CR7","doi-asserted-by":"crossref","unstructured":"Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, et al. incidence, prevalence, and mortality. Ren Replace Ther. 2020;6(1):41\u20131. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data,.","DOI":"10.1186\/s41100-020-00290-z"},{"key":"3271_CR8","doi-asserted-by":"crossref","unstructured":"Johansen KL, Chertow GM, Gilbertson DT, et al. Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2022;79(4 Suppl1):A8\u2013A12. US Renal Data System 2021 Annual Data Report:.","DOI":"10.1053\/j.ajkd.2022.02.001"},{"issue":"9","key":"3271_CR9","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1681\/ASN.2012080831","volume":"24","author":"T Kawaguchi","year":"2013","unstructured":"Kawaguchi T, Karaboyas A, Robinson BM, Li Y, Fukuhara S, Bieber BA, et al. Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality. J Am Soc Nephrol. 2013;24(9):1493\u2013502.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3271_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1053\/j.ajkd.2008.10.043","volume":"53","author":"RL Pisoni","year":"2009","unstructured":"Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis. 2009;53(3):475\u201391.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"3271_CR11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41598-020-79531-4","volume":"11","author":"X Zhao","year":"2021","unstructured":"Zhao X, Niu Q, Gan L, Hou FF, Liang X, Ni Z, et al. Baseline data report of the China Dialysis Outcomes and practice patterns study (DOPPS). Sci Rep. 2021;11(1):873.","journal-title":"Sci Rep"},{"issue":"1suppl","key":"3271_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/1129729819838183","volume":"20","author":"T Sato","year":"2019","unstructured":"Sato T, Sakurai H, Okubo K, Kusuta R, Onogi T, Tsuboi M. Current state of dialysis treatment and vascular access management in Japan. J Vasc Access. 2019;20(1suppl):10\u20134.","journal-title":"J Vasc Access"},{"issue":"z1","key":"3271_CR13","first-page":"15","volume":"11","author":"Mortality","year":"2012","unstructured":"Mortality. Causes of death among hemodialysis patients over the years. Chin J Blood Purif. 2012;11(z1):15\u201325.","journal-title":"Chin J Blood Purif"},{"issue":"1","key":"3271_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1080\/0886022X.2019.1612429","volume":"41","author":"Y Zou","year":"2019","unstructured":"Zou Y, Hong D, He Q, Wen Y, Li G. Epidemiology investigation and analysis of patients with hemodialysis in Sichuan province of China. Ren Fail. 2019;41(1):644\u201349.","journal-title":"Ren Fail"},{"issue":"02","key":"3271_CR15","first-page":"123","volume":"30","author":"L Jing Li","year":"2014","unstructured":"Jing Li L, Wang L, Cheng, et al. Epidemiological survey of hemodialysis patients in Shanxi Province from 2010 to 2012. Chin J Nephrol. 2014;30(02):123\u201327.","journal-title":"Chin J Nephrol"},{"issue":"1","key":"3271_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2215\/CJN.06320611","volume":"7","author":"S Shastri","year":"2012","unstructured":"Shastri S, Tangri N, Tighiouart H, Beck GJ, Vlagopoulos P, Ornt D, et al. Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study. Clin J Am Soc Nephrol. 2012;7(1):123\u201330.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"3271_CR17","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/ndt\/12.5.952","volume":"12","author":"K Takeda","year":"1997","unstructured":"Takeda K, Harada A, Okuda S, Fujimi S, Oh Y, Hattori F, et al. Sudden death in chronic dialysis patients. Nephrol Dial Transplant. 1997;12(5):952\u201355.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"3271_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.semnephrol.2018.08.003","volume":"38","author":"CM Rhee","year":"2018","unstructured":"Rhee CM, Chou JA, Kalantar-Zadeh K. Dialysis prescription and sudden death. Semin Nephrol. 2018;38(6):570\u201381.","journal-title":"Semin Nephrol"},{"issue":"10","key":"3271_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.5694\/mja18.00195","volume":"209","author":"WH Lim","year":"2018","unstructured":"Lim WH, Johnson DW, Hawley C, Lok C, Polkinghorne KR, Roberts MA, et al. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk. Med J Aust. 2018;209(10):440\u201346.","journal-title":"Med J Aust"},{"key":"3271_CR20","unstructured":"Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(1 Suppl 1):A7. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease."},{"issue":"03","key":"3271_CR21","first-page":"185","volume":"13","author":"X Zhao","year":"2014","unstructured":"Zhao X, Wang Y, Gan L, et al. Changes in the demographics and etiological composition of new maintenance hemodialysis patients in Beijing. Chin J Blood Purif. 2014;13(03):185\u201389.","journal-title":"Chin J Blood Purif"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03271-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03271-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T08:13:55Z","timestamp":1700208835000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03271-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3271"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03271-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"assertion":[{"value":"4 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study complied with the principle of the Declaration of Helsinki and was approved by the Bioethics Committee of Beijing Friendship Hospital, Capital Medical University (IRB number 2021-P2-211-01). The privacy and personally identifiable information of the patients in this study were protected. This study did not identify any patients, and the research project did not involve personal privacy and commercial interests. Therefore, the need for informed consent was waived by the Bioethics Committee of Beijing Friendship Hospital, Capital Medical University. All methods were carried out in accordance with relevant guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"236"}}